3,972 Shares in HealthEquity, Inc. (NASDAQ:HQY) Bought by Avanza Fonder AB

Avanza Fonder AB acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 3,972 shares of the company's stock, valued at approximately $381,000.

Other institutional investors have also bought and sold shares of the company. Paladin Wealth LLC acquired a new position in shares of HealthEquity during the 3rd quarter valued at about $39,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in HealthEquity in the 2nd quarter valued at about $73,000. GAMMA Investing LLC grew its stake in shares of HealthEquity by 57.8% in the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company's stock valued at $77,000 after buying an additional 344 shares during the period. Quarry LP increased its holdings in shares of HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after buying an additional 1,089 shares during the last quarter. Finally, 1620 Investment Advisors Inc. purchased a new stake in shares of HealthEquity during the 3rd quarter valued at approximately $112,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on HQY. Bank of America increased their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. Mizuho assumed coverage on HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target for the company. Royal Bank of Canada raised their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 10th. BTIG Research upped their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. Finally, Barrington Research lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $110.71.

Insider Activity

In other news, Director Frank Corvino sold 1,039 shares of the company's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares of the company's stock, valued at approximately $363,642.40. This represents a 21.54 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the sale, the director now directly owns 66,469 shares in the company, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 34,289 shares of company stock worth $3,355,718. 2.20% of the stock is currently owned by company insiders.

HealthEquity Stock Up 2.3 %

NASDAQ:HQY traded up $2.33 during midday trading on Monday, reaching $102.42. The company had a trading volume of 962,745 shares, compared to its average volume of 649,958. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $105.82. The firm has a market capitalization of $8.88 billion, a price-to-earnings ratio of 93.96, a PEG ratio of 1.77 and a beta of 0.54. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The stock's fifty day simple moving average is $98.90 and its 200-day simple moving average is $86.63.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.